Cargando…
A high‐throughput LC–MS/MS method for simultaneous determination of isoniazid, ethambutol and pyrazinamide in human plasma
RATIONALE: Tuberculosis (TB) remains a challenging global infectious disease, mainly affecting the lungs. First‐line anti‐TB drugs play a crucial role in slowing down the rapid spread of TB. In addition, the patient might benefit from therapeutic drug monitoring since it has become an accepted clini...
Autores principales: | Pršo, Kristián, Žideková, Nela, Porvazník, Igor, Solovič, Ivan, Mokrý, Juraj, Kertys, Martin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9787364/ https://www.ncbi.nlm.nih.gov/pubmed/36329637 http://dx.doi.org/10.1002/rcm.9425 |
Ejemplares similares
-
Pharmacokinetics of isoniazid, rifampicin, pyrazinamide and ethambutol in Indian children
por: Mukherjee, Aparna, et al.
Publicado: (2015) -
Pharmacokinetics of Isoniazid, Pyrazinamide, and Ethambutol in Newly Diagnosed Pulmonary TB Patients in Tanzania
por: Denti, Paolo, et al.
Publicado: (2015) -
Simultaneous determination of the potent anti-tuberculosis regimen—Pyrazinamide, ethambutol, protionamide, clofazimine in beagle dog plasma using LC–MS/MS method coupled with 96-well format plate
por: Wu, Shengyuan, et al.
Publicado: (2019) -
Whole Genome Sequencing in the Management of Non-Tuberculous Mycobacterial Infections
por: Dohál, Matúš, et al.
Publicado: (2021) -
Advancing tuberculosis management: the role of predictive, preventive, and personalized medicine
por: Dohál, Matúš, et al.
Publicado: (2023)